Cargando…
Wnt signalling in adenomas of familial adenomatous polyposis patients
BACKGROUND: Epigenetic silencing of Wnt antagonists and expression changes in genes associated with Wnt response pathways occur in early sporadic colorectal tumourigenesis, indicating that tumour cells are more sensitive to Wnt growth factors and respond differently. In this study, we have investiga...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966613/ https://www.ncbi.nlm.nih.gov/pubmed/20628379 http://dx.doi.org/10.1038/sj.bjc.6605790 |
_version_ | 1782189603640311808 |
---|---|
author | Caldwell, G M Jones, C E Ashley, A M Wei, W Hejmadi, R K Morton, D G Matthews, G M |
author_facet | Caldwell, G M Jones, C E Ashley, A M Wei, W Hejmadi, R K Morton, D G Matthews, G M |
author_sort | Caldwell, G M |
collection | PubMed |
description | BACKGROUND: Epigenetic silencing of Wnt antagonists and expression changes in genes associated with Wnt response pathways occur in early sporadic colorectal tumourigenesis, indicating that tumour cells are more sensitive to Wnt growth factors and respond differently. In this study, we have investigated whether similar changes occur in key markers of the Wnt response pathways in the genetic form of the disease, familial adenomatous polyposis (FAP). METHODS: We investigated epigenetic and expression changes using pyrosequencing and real-time RT-PCR in samples from seven patients without neoplasia, and matched normal and tumour tissues from 22 sporadic adenoma and 14 FAP patients. RESULTS: We found that 17 out of 24 (71%) FAP adenomas were hypermethylated at sFRP1, compared with 20 out of 22 (91%) of sporadic cases. This was reflected at the level of sFRP1 transcription, where 73% of FAP and 100% of sporadic cases were down-regulated. Increased expression levels of c-myc and FZD3 were less common in FAP (35 and 46% respectively) than sporadic tumours (78 and 67% respectively). CONCLUSION: Overall, the changes in expression and methylation were comparable, although the degree of change was generally lower in the FAP adenomas. Molecular heterogeneity between multiple adenomas from individual FAP patients may reflect different developmental fates for these premalignant tumours. |
format | Text |
id | pubmed-2966613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-29666132011-09-07 Wnt signalling in adenomas of familial adenomatous polyposis patients Caldwell, G M Jones, C E Ashley, A M Wei, W Hejmadi, R K Morton, D G Matthews, G M Br J Cancer Genetics and Genomics BACKGROUND: Epigenetic silencing of Wnt antagonists and expression changes in genes associated with Wnt response pathways occur in early sporadic colorectal tumourigenesis, indicating that tumour cells are more sensitive to Wnt growth factors and respond differently. In this study, we have investigated whether similar changes occur in key markers of the Wnt response pathways in the genetic form of the disease, familial adenomatous polyposis (FAP). METHODS: We investigated epigenetic and expression changes using pyrosequencing and real-time RT-PCR in samples from seven patients without neoplasia, and matched normal and tumour tissues from 22 sporadic adenoma and 14 FAP patients. RESULTS: We found that 17 out of 24 (71%) FAP adenomas were hypermethylated at sFRP1, compared with 20 out of 22 (91%) of sporadic cases. This was reflected at the level of sFRP1 transcription, where 73% of FAP and 100% of sporadic cases were down-regulated. Increased expression levels of c-myc and FZD3 were less common in FAP (35 and 46% respectively) than sporadic tumours (78 and 67% respectively). CONCLUSION: Overall, the changes in expression and methylation were comparable, although the degree of change was generally lower in the FAP adenomas. Molecular heterogeneity between multiple adenomas from individual FAP patients may reflect different developmental fates for these premalignant tumours. Nature Publishing Group 2010-09-07 2010-07-13 /pmc/articles/PMC2966613/ /pubmed/20628379 http://dx.doi.org/10.1038/sj.bjc.6605790 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Genetics and Genomics Caldwell, G M Jones, C E Ashley, A M Wei, W Hejmadi, R K Morton, D G Matthews, G M Wnt signalling in adenomas of familial adenomatous polyposis patients |
title | Wnt signalling in adenomas of familial adenomatous polyposis patients |
title_full | Wnt signalling in adenomas of familial adenomatous polyposis patients |
title_fullStr | Wnt signalling in adenomas of familial adenomatous polyposis patients |
title_full_unstemmed | Wnt signalling in adenomas of familial adenomatous polyposis patients |
title_short | Wnt signalling in adenomas of familial adenomatous polyposis patients |
title_sort | wnt signalling in adenomas of familial adenomatous polyposis patients |
topic | Genetics and Genomics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966613/ https://www.ncbi.nlm.nih.gov/pubmed/20628379 http://dx.doi.org/10.1038/sj.bjc.6605790 |
work_keys_str_mv | AT caldwellgm wntsignallinginadenomasoffamilialadenomatouspolyposispatients AT jonesce wntsignallinginadenomasoffamilialadenomatouspolyposispatients AT ashleyam wntsignallinginadenomasoffamilialadenomatouspolyposispatients AT weiw wntsignallinginadenomasoffamilialadenomatouspolyposispatients AT hejmadirk wntsignallinginadenomasoffamilialadenomatouspolyposispatients AT mortondg wntsignallinginadenomasoffamilialadenomatouspolyposispatients AT matthewsgm wntsignallinginadenomasoffamilialadenomatouspolyposispatients |